News & Events
Biotech and Agribusiness Leader Joins Chromatin, Inc. Board of Directors
John A. Greaves, Ph.D., Kemin Industries' Worldwide Director, Specialty Crop Improvement, Joins Board of Plant Science Company
CHICAGO, IL - March 25, 2010 - Today, Chromatin, Inc. announced the appointment of Dr. John A. Greaves, Ph.D., Worldwide Director, Specialty Crop Improvement at Kemin Industries, Inc., to the company's Board of Directors. The addition of Dr. Greaves will allow Chromatin to gain significant insight from his leadership in crop development and biotechnology operations, as the company readies itself for the production of products supporting the energy feedstock sector.
"I am extremely pleased to welcome John to our Board of Directors," said Daphne Preuss, Chromatin's CEO. "John's experience in developing crop products for new markets will be an important asset as we build on Chromatin's innovative technology capabilities to create high-value energy feedstock products."
Dr. Greaves has over twenty-one years of agribusiness experience in the biotechnology industry. In his current role as the Worldwide Director, Specialty Crop Improvement at Kemin Industries, Inc., Dr. Greaves coordinates a global team of plant breeders, horticulturalists, analytical chemists and field agronomists with research programs located in the USA, China and India using plants to produce target molecules. Previously, Dr. Greaves has held several executive roles, including: President of Hy-Line International, President of Kemin Agri-Foods, North America, and Vice President of Research & Development for Kemin Industries, Inc. and Kemin Biotechnology, L.C. Upon completion of his Ph.D., Dr. Greaves spent eight years building a unique gene discovery and trait introgression program in corn as the Trait Breeding Manager at ICI Seeds.
"This is an exciting time to join the Chromatin board," said Greaves. "The company is well positioned to capture several high-value opportunities."
"At this important juncture in our company's trajectory, Greaves brings the operational insights and real-world experience that will drive value as we enter a phase of rapid growth," said John Hamer, Chairman of the Chromatin Board of Directors.
About Chromatin:
Chromatin, Inc. is developing and marketing innovative technology and products that can benefit the agricultural, energy, chemical, nutritional, and pharmaceutical sectors. Its proprietary gene stacking technology can be used in any plant to simultaneously and precisely introduce multiple genes, and this technology has been licensed to leading agbiotech companies for use in corn, soy, cotton, canola and sugarcane. Chromatin is building on this platform to create next generation crop products that are better designed to meet yield and performance requirements, including products targeted to the renewable energy industry.
For additional information visit www.chromatininc.com.
Media Contact:
Marc Tamo
Blue Practice for Chromatin, Inc.
415/987-2583
marc@bluepractice.com